Advertisement

Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends

      Objective

      To estimate leiomyoma-related inpatient care in the United States for 2007 with predictions for the ensuing 40 years.

      Study Design

      We used the 2007 Nationwide Inpatient Sample to estimate hospitalizations and inpatient surgeries for uterine leiomyoma in US women 15 to 54 years. We used the US Census Bureau population projections to predict leiomyoma-related inpatient care through 2050.

      Results

      In 2007, 355,135 women were hospitalized for leiomyoma (rate = 42 per 10,000 women-years). Black women had increased rates of hospitalization, hysterectomy, and myomectomy (relative risk, 3.5, 2.4, 6.8, respectively) compared with white women. Leiomyoma-related hospitalizations are predicted to increase 23% (to 437,874) between 2007 and 2050, with 20% and 31% increases in leiomyoma-related hysterectomies and myomectomies.

      Conclusion

      Leiomyoma-related inpatient care and major surgery remains substantial despite advances in less invasive treatment options. Given population growth, the projected burden of leiomyoma-related inpatient care will increase significantly by 2050, differentially impacting black vs white women.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Baird D.D.
        • Dunson D.B.
        • Hill M.C.
        • Cousins D.
        • Schectman J.M.
        High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
        Am J Obstet Gynecol. 2003; 188: 100-107
        • Spies J.B.
        • Bradley L.D.
        • Guido R.
        • Maxwell G.L.
        • Levine B.A.
        • Coyne K.
        Outcomes from leiomyoma therapies: comparison with normal controls.
        Obstet Gynecol. 2010; 116: 641-652
        • Hartmann K.E.
        • Birnbaum H.
        • Ben-Hamadi R.
        • et al.
        Annual costs associated with diagnosis of uterine leiomyomata.
        Obstet Gynecol. 2006; 108: 930-937
        • Klatsky P.C.
        • Tran N.D.
        • Caughey A.B.
        • Fujimoto V.Y.
        Fibroids and reproductive outcomes: a systematic literature review from conception to delivery.
        Am J Obstet Gynecol. 2008; 198: 357-366
        • Flynn M.
        • Jamison M.
        • Datta S.
        • Myers E.
        Health care resource use for uterine fibroid tumors in the United States.
        Am J Obstet Gynecol. 2006; 195: 955-964
        • Lee D.W.
        • Ozminkowski R.J.
        • Carls G.S.
        • Wang S.
        • Gibson T.B.
        • Stewart E.A.
        The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids.
        J Occup Environ Med. 2007; 49: 493-506
        • Whiteman M.K.
        • Hillis S.D.
        • Jamieson D.J.
        • et al.
        Inpatient hysterectomy surveillance in the United States, 2000-2004.
        Am J Obstet Gynecol. 2008; 198: 34.e1-34.e7
        • Keshavarz H.
        • Hillis S.D.
        • Kieke Ba
        • Marchbanks P.A.
        Hysterectomy surveillance—United States, 1994-1999.
        MMWR CDC Surveill Summ. 2002; 51: 1-8
        • Marshall L.M.
        • Spiegelman D.
        • Barbieri R.L.
        • et al.
        Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.
        Obstet Gynecol. 1997; 90: 967-973
        • Wise L.A.
        • Palmer J.R.
        • Stewart E.A.
        • Rosenberg L.
        Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
        Obstet Gynecol. 2005; 105: 563-568
        • Wallace A.H.
        • Havrilesky L.J.
        • Valea F.A.
        • Barnett J.C.
        • Berchuck A.
        • Myers E.R.
        Projecting the need for gynecologic oncologists for the next 40 years.
        Obstet Gynecol. 2010; 116: 1366-1372
        • HCUP Nationwide Inpatient Sample (NIS)
        Agency for Healthcare Research and Quality, 2007.
        (Accessed July 18, 2009)
      1. Annual estimates of the population by sexfive-year age groups for the United States: April 1, 2000 to July 1, 2007 (NC-EST2007-01).
        (Accessed July 1, 2010)
      2. NP2008_D1: Projected population by single year of age, sex, race, and Hispanic origin for the United States: July 1, 2000 to July 1, 2050.
        (Accessed July 1, 2010)
      3. Methodology and Assumptions for the Population Projections of the United States: 1999 to 2100.
        (Accessed July 1, 2010)
        • Day J.C.
        Population projections of the united states by age, sex, race, and Hispanic origin: 1995 to 2050.
        U.S. Bureau of the Census, Washington, DC1996
        • Templeman C.
        • Marshall S.F.
        • Clarke C.A.
        • et al.
        Risk factors for surgically removed fibroids in a large cohort of teachers.
        Fertil Steril. 2009; 92: 1436-1446
        • Huyck K.L.
        • Panhuysen C.I.
        • Cuenco K.T.
        • et al.
        The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters.
        Am J Obstet Gynecol. 2008; 198: 168.e1-168.e9
        • Kjerulff K.H.
        • Langenberg P.
        • Seidman J.D.
        • Stolley P.D.
        • Guzinski G.M.
        Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis.
        J Reprod Med. 1996; 41: 483-490
        • Laughlin S.K.
        • Baird D.D.
        • Savitz D.A.
        • Herring A.H.
        • Hartmann K.E.
        Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.
        Obstet Gynecol. 2009; 113: 630-635
        • Peddada S.D.
        • Laughlin S.K.
        • Miner K.
        • et al.
        Growth of uterine leiomyomata among premenopausal black and white women.
        Proc Natl Acad Sci U S A. 2008; 105: 19887-19892
        • Hall M.J.
        • DeFrances C.J.
        • Williams S.N.
        • Golosinskiy A.
        • Schwartzman A.
        National hospital discharge survey: 2007 summary.
        National Center for Health Statistics, Hyattsville, MD2010
        • Mauskopf J.
        • Flynn M.
        • Thieda P.
        • Spalding J.
        • Duchane J.
        The economic impact of uterine fibroids in the United States: a summary of published estimates.
        J Womens Health (Larchmt). 2005; 14: 692-703
        • Whiteman M.K.
        • Kuklina E.
        • Jamieson D.J.
        • Hillis S.D.
        • Marchbanks P.A.
        Inpatient hospitalization for gynecologic disorders in the United States.
        Am J Obstet Gynecol. 2010; 202: 541.e1-541.e6
        • Jacoby V.L.
        • Fujimoto V.Y.
        • Giudice L.C.
        • Kuppermann M.
        • Washington A.E.
        Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.
        Am J Obstet Gynecol. 2010; 202: 514-521
        • Luoto R.
        • Raitanen J.
        • Pukkala E.
        • Anttila A.
        Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010.
        Br J Cancer. 2004; 90: 1756-1759
        • Wu J.M.
        • Hundley A.F.
        • Fulton R.G.
        • Myers E.R.
        Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.
        Obstet Gynecol. 2009; 114: 1278-1283